Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge

Abstract SARS-CoV-2 is a viral respiratory pathogen responsible for the current global pandemic and the disease that causes COVID-19. All current WHO approved COVID-19 vaccines are administered through the muscular route. We have developed a prototype two-dose vaccine (BReC-CoV-2) by combining the R...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, Alexander M. Horspool, Jason Kang, Michael T. Winters, M. Allison Wolf, Nathaniel A. Rader, Olivia A. Miller, Morgane Shiflett, Jerilyn Izac, David Varisco, Emel Sen-Kilic, Casey Cunningham, Melissa Cooper, Holly A. Cyphert, Mariette Barbier, Ivan Martinez, Justin R. Bevere, Robert K. Ernst, F. Heath Damron
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Nature Portfolio 2022-03-01
Colección:	npj Vaccines
Acceso en línea:	https://doi.org/10.1038/s41541-022-00451-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!